Unlike the noncancerous cells, in SFT cancer cells the fusion of NAB2 and STAT6 transcripts create novel sequences at the junction site (e.g., 5′-CCTCTCGCAG|CTGAACAGAT-3′ for NAB2exon6–STAT6exon17 fusion type, | denotes the breakpoint), which could serve as the basis for fusion-specific RNA targeting. This evidence concerns the gene NAB2 and cancer.